Blood Type Ups COVID Risk; IV Vitamin Craze; Suicide Risk in Transgender People

Note that some links may require subscriptions.

SARS-CoV-2, the virus that causes COVID-19, "preferentially infects" blood group A cells, researchers found. (Blood)

Restricting yourself to light or moderate drinking, rather than heavy drinking, doesn't appear to decrease the risk of obesity or diabetes, Canadian researchers found. (Journal of Clinical Endocrinology & Metabolism)

AI -- what is it good for? Helping doctors with visit documentation, that's what. (New York Times)

Why do some statin users get achy muscles? Researchers now think they know the answer. (The Atlantic)

Another case report shows chimeric antigen receptor (CAR) T-cell therapy may find a place in autoimmune diseases. (JAMA)

Americans are pumping vitamin cocktails into their veins. (Fox News)

Being unhoused and not receiving medical bills ended up becoming expensive for a 23-year-old Tennessee resident. (KFF Health News)

The FDA gave a thumbs down to Regeneron's higher dose of aflibercept (Eylea) for treating various eye conditions, including wet age-related macular degeneration; the agency cited an ongoing review of inspection findings at a third-party filler, the company said.

Meanwhile, Roche received FDA clearance for two cerebrospinal fluid assays for Alzheimer's disease, the company announced.

In other FDA news, the agency withdrew approval for Gemini Laboratories' anabolic steroid oxandrolone (Oxandrin), citing multiple safety precautions and warnings over many years, including associations with liver failure and intra-abdominal hemorrhage. (Endpoints News)

Transgender people have a significantly higher risk of suicide, according to results from a study using data from Denmark. (JAMA)

If you want to lose weight, which is better: time-restricted eating or calorie restriction? Actually, both work equally well, investigators found. (Annals of Internal Medicine)

Mothers who had COVID-19 during pregnancy were younger and had lower education levels compared with mothers who did not have COVID-19, a CDC study of patients who gave birth between July 2020 and June 2022 found.

Nearly 36 million people in Europe -- or about 1 in 30 Europeans -- have experienced long COVID, the WHO said.

The popularity of the weight-loss drug semaglutide (Wegovy) has some employers reconsidering whether they should cover it. (Reuters)

Comment